1.
Strausberg RL, Schreiber SL. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science. 2003;300(5617):294-5. doi:10.1126/science.1083395.
1.
Lloyd-Price J, Mahurkar A, Rahnavard G, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. 2017;550(7674):61-66. doi:10.1038/nature23889.
1.
Keenan AB, Jenkins SL, Jagodnik KM, et al. The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. Cell Syst. 2018;6(1):13-24. doi:10.1016/j.cels.2017.11.001.
1.
Wolf SM, Amendola LM, Berg JS, et al. Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. Genet Med. 2018;20(5):545-553. doi:10.1038/gim.2017.137.
1.
HuBMAP Consortium. The human body at cellular resolution: the NIH Human Biomolecular Atlas Program. Nature. 2019;574(7777):187-192. doi:10.1038/s41586-019-1629-x.
1.
Hoover P, Der E, Berthier CC, et al. Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis. Arthritis Care Res (Hoboken). 2020;72(2):233-242. doi:10.1002/acr.24066.
1.
Tolliday N, Clemons PA, Ferraiolo P, et al. Small molecules, big players: the National Cancer Institute’s Initiative for Chemical Genetics. Cancer Res. 2006;66(18):8935-42. doi:10.1158/0008-5472.CAN-06-2552.
1.
Reed JC, White L, Aubé J, et al. The NIH’s role in accelerating translational sciences. Nat Biotechnol. 2012;30(1):16-9. doi:10.1038/nbt.2087.
1.
Hyman SE. Time for new schizophrenia Rx. Science. 2014;343(6176):1177. doi:10.1126/science.1252603.
1.
Huttenhower C, Knight R, Brown T, et al. Advancing the microbiome research community. Cell. 2014;159(2):227-30. doi:10.1016/j.cell.2014.09.022.